Intersect ENT Inc (NASDAQ:XENT)

24.69
Delayed Data
As of May 05
 -1.80 / -6.80%
Today’s Change
12.02
Today|||52-Week Range
28.80
+33.10%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close26.49
Today’s open26.29
Day’s range-- - --
Volume146,712
Average volume (3 months)177,101
Market cap$626.1M
Dividend yield--
Data as of 05/05/2015

Growth & Valuation

Earnings growth (last year)-455.17%
Earnings growth (this year)+36.14%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+111.29%
P/E ratioNM
Price/Sales5.57
Price/Book11.51

Competitors

 Today’s
change
Today’s
% change
ATRIAtrion Corp+3.24+0.99%
BLCMBellicum Pharmaceuti...-0.55-2.38%
ANGOAngioDynamics Inc-0.31-1.84%
ATRCAtriCure Inc+0.07+0.31%
Data as of 05/05/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$37.9M
Annual profit (last year)-$18.4M
Net profit margin-48.47%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers